{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:50:37Z","timestamp":1789876237404,"version":"4.0.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.japh.2020.09.020","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T20:08:18Z","timestamp":1602706098000},"page":"e75-e79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Patient perspectives of pharmacists prescribing HIV pre-exposure prophylaxis: A survey of patients receiving antiretroviral therapy"],"prefix":"10.1016","volume":"61","author":[{"given":"Susan","family":"Lutz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2895-6541","authenticated-orcid":false,"given":"Monica","family":"Heberling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9736-0891","authenticated-orcid":false,"given":"Kellie J.","family":"Goodlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2020.09.020_bib4","article-title":"Geographic access to PrEP clinics among U.S. MSM: documenting PrEP deserts","author":"Weiss","year":"2018","journal-title":"The Conference of Retrovirus and Opportunistic Infections (Boston, MA)"},{"issue":"6","key":"10.1016\/j.japh.2020.09.020_bib7","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1071\/SH18084","article-title":"Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care","volume":"15","author":"Tung","year":"2018","journal-title":"Sex Health"},{"issue":"2","key":"10.1016\/j.japh.2020.09.020_bib8","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/cid\/ciy640","article-title":"A\u00a0PrEP model incorporating clinical pharmacist encounters and antimicrobial stewardship program oversight may improve retention in care","volume":"68","author":"Gauthier","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.japh.2020.09.020_bib9","doi-asserted-by":"crossref","first-page":"ofz365","DOI":"10.1093\/ofid\/ofz365","article-title":"Acceptability and feasibility of a pharmacist-led HIV pre-exposure prophylaxis (PrEP) program in the Midwestern United States","volume":"6","author":"Havens","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.japh.2020.09.020_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/apc.2019.0235","article-title":"A\u00a0pharmacist-led, same-day, HIV pre-exposure prophylaxis initiation program to increase PrEP uptake and decrease time to PrEP Initiation","volume":"34","author":"Khosropour","year":"2020","journal-title":"AIDS Patient Care STDs"},{"issue":"1","key":"10.1016\/j.japh.2020.09.020_bib11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.japh.2019.06.021","article-title":"Implementation of pre-exposure prophylaxis at a community pharmacy through a collaborative practice agreement with San Francisco Department of Public Health","volume":"60","author":"Lopez","year":"2020","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2020.09.020_bib12","article-title":"Patient perception of community pharmacists prescribing pre-exposure prophylaxis for HIV prevention [e-pub ahead of print]","author":"Zhu","year":"2003","journal-title":"J\u00a0Am Pharm Assoc"},{"key":"10.1016\/j.japh.2020.09.020_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pmedr.2018.10.023","article-title":"A\u00a0qualitative exploration of facilitators and barriers to meningitis vaccination uptake among men who have sex with men","volume":"13","author":"Johnson","year":"2019","journal-title":"Prev Med Rep"},{"key":"10.1016\/j.japh.2020.09.020_bib14","series-title":"Patient-provider communication about sexual behaviors and pre-exposure prophylaxis: results from a national online survey of men who have sex with men in the United States. 8th Conference on HIV Pathogenesis, Treatment and Prevention (Vancouver)","author":"Krakower","year":"2015"},{"key":"10.1016\/j.japh.2020.09.020_bib15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1186\/1471-2458-10-517","article-title":"Stigmatizing attitudes and low levels of knowledge but high willingness to participate in HIV management: a community-based survey of pharmacies in Pune, India","volume":"10","author":"Gupta","year":"2010","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.japh.2020.09.020_bib16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/0897190013513301","article-title":"Community-based pharmacists\u2019 needs for HIV-related training and experience","volume":"27","author":"Kibicho","year":"2014","journal-title":"J\u00a0Pharm Pract"},{"issue":"5","key":"10.1016\/j.japh.2020.09.020_bib17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/0897190010367431","article-title":"Antiretroviral medication knowledge among New York State pharmacists: room for improvement","volume":"23","author":"Jodlowski","year":"2010","journal-title":"J\u00a0Pharm Pract"},{"issue":"2","key":"10.1016\/j.japh.2020.09.020_bib18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/pharmacy8020084","article-title":"A\u00a0narrative review of continuing professional development needs for pharmacists with respect to pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV)","volume":"8","author":"Wilby","year":"2020","journal-title":"Pharmacy (Basel)"},{"issue":"6","key":"10.1016\/j.japh.2020.09.020_bib19","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1331\/JAPhA.2014.14014","article-title":"Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis","volume":"54","author":"Shaeer","year":"2014","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"9","key":"10.1016\/j.japh.2020.09.020_bib20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1093\/ajhp\/zxaa086","article-title":"California readies for implementation of historic law aimed at curbing HIV","volume":"77","author":"Gregory","year":"2020","journal-title":"Am J Health Syst Pharm"},{"issue":"5","key":"10.1016\/j.japh.2020.09.020_bib21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"Baeten","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"27","key":"10.1016\/j.japh.2020.09.020_bib22","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men","volume":"363","author":"Grant","year":"2010","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.japh.2020.09.020_bib23","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S1473-3099(13)70226-3","article-title":"Sexual behaviour of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: a longitudinal analysis","volume":"13","author":"Mugwanya","year":"2013","journal-title":"Lancet Infect Dis"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319120304817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319120304817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:47:58Z","timestamp":1761544078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319120304817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1544319120304817"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2020.09.020","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient perspectives of pharmacists prescribing HIV pre-exposure prophylaxis: A survey of patients receiving antiretroviral therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2020.09.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}